ERBB2 and cancer: In our analysis, features of cancer aggressiveness, such as levels of Ki-67 ≥ 20%, and the HER2-positive molecular subtype, were associated with higher conspicuity in univariate analysis; in contrast, Luminal A tumors were more commonly observed in the low-LC group.